Timing the Scan: Optimizing Screening for Osteoporosis and Risk of Fracture in Celiac Disease.

IF 7.6 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY
Francesco Tovoli, Guido Zavatta, Giovanni Monaco, Dante Pio Pallotta, Kinga Skoracka, Alberto Raiteri, Agnese Pratelli, Maria Boe, Iwona Krela-Kaźmierczak, Uberto Pagotto, Alessandro Granito
{"title":"Timing the Scan: Optimizing Screening for Osteoporosis and Risk of Fracture in Celiac Disease.","authors":"Francesco Tovoli, Guido Zavatta, Giovanni Monaco, Dante Pio Pallotta, Kinga Skoracka, Alberto Raiteri, Agnese Pratelli, Maria Boe, Iwona Krela-Kaźmierczak, Uberto Pagotto, Alessandro Granito","doi":"10.14309/ajg.0000000000003750","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Patients with celiac disease (CeD) have an increased risk of osteoporosis and fractures, but the ideal timing for bone mineral density (BMD) assessment remains unclear due to conflicting recommendations. This study evaluated the optimal timing for dual-energy x-ray absorptiometry (DXA) screening considering different clinical targets: early detection of BMD alterations, osteoporosis diagnosis, or fracture risk stratification.</p><p><strong>Methods: </strong>Observational study prospectively enrolling 627 patients with CeD (>25 years) who underwent DXA scans of the lumbar spine and hip as part of standard care. Data on clinical presentation, serology, histology, and fracture risk were analyzed. Logistic regression identified risk factors of low BMD and osteoporosis. The reliability of the National Osteoporosis Guidelines Group (NOGG) guidelines for avoiding unnecessary DXAs was assessed.</p><p><strong>Results: </strong>Low BMD for age was present in 17.2% of patients, with significant prevalence in the 25-34 years age group (13.4%), further increasing in the 45-54 years age group. Osteoporosis was detected in 17.9% of patients, with prevalence increasing significantly in patients aged older than 45 years. Risk factors included weight loss, underweight status, and iron-deficiency anemia. Using the NOGG criteria, 67% of patients could have avoided DXA, with a 0.5% risk of missing clinically significant findings requiring treatment (but also losing 15.7% patients with low BMD for age).</p><p><strong>Discussion: </strong>The ideal timing for DXA screening in patients with CeD depends on the clinical objective. DXA at diagnosis maximizes the early detection of low bone mass, whereas the NOGG criteria effectively identified patients at high risk of fractures, reducing unnecessary scans. However, their use should be weighed against an underdetection of clinically relevant BMD alterations. Tailoring DXA timing to healthcare resources and patient demographics may optimize outcomes and resource allocation.</p>","PeriodicalId":7608,"journal":{"name":"American Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":7.6000,"publicationDate":"2025-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.14309/ajg.0000000000003750","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Patients with celiac disease (CeD) have an increased risk of osteoporosis and fractures, but the ideal timing for bone mineral density (BMD) assessment remains unclear due to conflicting recommendations. This study evaluated the optimal timing for dual-energy x-ray absorptiometry (DXA) screening considering different clinical targets: early detection of BMD alterations, osteoporosis diagnosis, or fracture risk stratification.

Methods: Observational study prospectively enrolling 627 patients with CeD (>25 years) who underwent DXA scans of the lumbar spine and hip as part of standard care. Data on clinical presentation, serology, histology, and fracture risk were analyzed. Logistic regression identified risk factors of low BMD and osteoporosis. The reliability of the National Osteoporosis Guidelines Group (NOGG) guidelines for avoiding unnecessary DXAs was assessed.

Results: Low BMD for age was present in 17.2% of patients, with significant prevalence in the 25-34 years age group (13.4%), further increasing in the 45-54 years age group. Osteoporosis was detected in 17.9% of patients, with prevalence increasing significantly in patients aged older than 45 years. Risk factors included weight loss, underweight status, and iron-deficiency anemia. Using the NOGG criteria, 67% of patients could have avoided DXA, with a 0.5% risk of missing clinically significant findings requiring treatment (but also losing 15.7% patients with low BMD for age).

Discussion: The ideal timing for DXA screening in patients with CeD depends on the clinical objective. DXA at diagnosis maximizes the early detection of low bone mass, whereas the NOGG criteria effectively identified patients at high risk of fractures, reducing unnecessary scans. However, their use should be weighed against an underdetection of clinically relevant BMD alterations. Tailoring DXA timing to healthcare resources and patient demographics may optimize outcomes and resource allocation.

定时扫描:优化筛查骨质疏松症和乳糜泻骨折风险。
背景:乳糜泻(CeD)患者骨质疏松和骨折的风险增加,但由于相互矛盾的建议,评估骨密度(BMD)的理想时机仍不清楚。本研究评估了双能x线吸收仪(DXA)筛查的最佳时机,考虑了不同的临床目标:早期发现BMD改变,骨质疏松症诊断或骨折风险分层。方法:观察性研究前瞻性纳入627例CeD患者(50 ~ 25岁),这些患者接受腰椎和髋关节DXA扫描作为标准治疗的一部分。分析临床表现、血清学、组织学和骨折风险的数据。Logistic回归确定了低骨密度和骨质疏松症的危险因素。评估国家骨质疏松指南小组(NOGG)指南在避免不必要的DXAs方面的可靠性。结果:17.2%的患者存在低骨密度,其中25-34岁年龄组患病率显著(13.4%),45-54岁年龄组患病率进一步上升。17.9%的患者检测到骨质疏松症,45岁以上患者的患病率明显增加。危险因素包括体重减轻、体重过轻和缺铁性贫血。使用NOGG标准,67%的患者可以避免DXA,有0.5%的风险缺少需要治疗的临床重要发现(但也有15.7%的低骨密度患者失去年龄)。结论:CeD患者DXA筛查的理想时机取决于临床目的。诊断时的DXA可最大限度地早期发现低骨量,而NOGG标准可有效识别骨折高危患者,减少不必要的扫描。然而,它们的使用应该与临床相关的骨密度改变检测不足进行权衡。根据医疗保健资源和患者人口统计数据定制DXA时间可以优化结果和资源分配。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
American Journal of Gastroenterology
American Journal of Gastroenterology 医学-胃肠肝病学
CiteScore
11.40
自引率
5.10%
发文量
458
审稿时长
12 months
期刊介绍: Published on behalf of the American College of Gastroenterology (ACG), The American Journal of Gastroenterology (AJG) stands as the foremost clinical journal in the fields of gastroenterology and hepatology. AJG offers practical and professional support to clinicians addressing the most prevalent gastroenterological disorders in patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信